A Study of Phenolic Bioactive Compounds Of Daucus Carota Subsp. Sativus Fruits of Yaskrava, Nantska Kharkivska and Olenka Species and Of Dauci Carotae Subsp. Sativi Fructuum Extractum Siccum

European Pharmaceutical Journal Pub Date : 2022-01-01 DOI:10.2478/afpuc-2022-0002

V. Kyslychenko, V. Protska, L. Horiacha, M. Liaudanskas, V. Žvikas, S. Trumbeckaitė, L. Ivanauskas, V. Jakštas, O. Kyslychenko, I. Zhuravel, L. Andriukova, N. Filyanina

{"title":"A Study of Phenolic Bioactive Compounds Of Daucus Carota Subsp. Sativus Fruits of Yaskrava, Nantska Kharkivska and Olenka Species and Of Dauci Carotae Subsp. Sativi Fructuum Extractum Siccum","authors":"V. Kyslychenko, V. Protska, L. Horiacha, M. Liaudanskas, V. Žvikas, S. Trumbeckaitė, L. Ivanauskas, V. Jakštas, O. Kyslychenko, I. Zhuravel, L. Andriukova, N. Filyanina","doi":"10.2478/afpuc-2022-0002","DOIUrl":null,"url":null,"abstract":"Abstract The objective of the work was to study the qualitative composition and determine the quantitative content of phenolic compounds of Daucus carota subsp. sativus fruits of Yaskrava, Nantska Kharkivska and Olenka species and of Dauci carotae subsp. sativi fructuum extractum siccum. Phenolic compounds were studied by UPLC-ESI-MS/MS method. High content of phenol-origin bioactive substances was fixed in Daucus carota subsp. sativus fruits of Nantska Kharkivska variety (363.19 μg/g). Dominating compounds were chlorogenic acid, cynaroside, rutin and hyperoside. Daucus carota subsp. sativus fruits of all study species under question were found to possess permanent qualitative composition of phenolic compounds, whereas their quantitative content in experimental samples differed slightly. The results of analysis confirm promising development of novel antioxidant and cardioprotective drugs on the basis of Dauci carotae subsp. sativi fructuum extractum siccum.","PeriodicalId":12070,"journal":{"name":"European Pharmaceutical Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/afpuc-2022-0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Abstract The objective of the work was to study the qualitative composition and determine the quantitative content of phenolic compounds of Daucus carota subsp. sativus fruits of Yaskrava, Nantska Kharkivska and Olenka species and of Dauci carotae subsp. sativi fructuum extractum siccum. Phenolic compounds were studied by UPLC-ESI-MS/MS method. High content of phenol-origin bioactive substances was fixed in Daucus carota subsp. sativus fruits of Nantska Kharkivska variety (363.19 μg/g). Dominating compounds were chlorogenic acid, cynaroside, rutin and hyperoside. Daucus carota subsp. sativus fruits of all study species under question were found to possess permanent qualitative composition of phenolic compounds, whereas their quantitative content in experimental samples differed slightly. The results of analysis confirm promising development of novel antioxidant and cardioprotective drugs on the basis of Dauci carotae subsp. sativi fructuum extractum siccum.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

胡萝卜素酚类生物活性化合物的研究。Yaskrava、Nantska Kharkivska和Olenka种的Sativus果实和Dauci胡萝卜科亚种。仙人掌提取物

摘要研究了角豆亚种酚类化合物的定性组成和含量。Yaskrava、Nantska Kharkivska和Olenka种和Dauci carotae亚种的sativus果实。细辛提取物。采用UPLC-ESI-MS/MS方法对酚类化合物进行了研究。高含量的酚类生物活性物质被固定在胡萝卜亚种中。南特斯卡-哈尔科夫斯卡品种（363.19μ。主要成分为绿原酸、布麻苷、芦丁和金丝桃苷。角豆亚种。研究中发现，所有研究物种的马齿苋果实都具有永久的酚类化合物定性组成，而它们在实验样品中的定量含量略有不同。分析结果证实了在胡萝卜素亚种的基础上开发新的抗氧化和心脏保护药物的前景。细辛提取物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European Pharmaceutical Journal Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

0.60

自引率

0.00%

发文量

期刊介绍： European Pharmaceutical Journal publishes only original articles not previously published and articles that are not being considered or have not been submitted for publication elsewhere. If parts of the results have been published as conference abstract or elsewhere, it should be stated in references. The ethical standards of the Helsinki-Tokio Declaration should be kept. This should be mentioned in the Methods of manuscript. Reviews are published only on request. Authors, whose submitted research work was performed with the support of a company, should indicate this in Conflict of Interest.